Nacis Jacus S, Labrador Jason Paolo H, Ronquillo Diana Glades D, Rodriguez Marietta P, Dablo Aurora Maria Francesca D, Frane Ruby D, Madrid Marilou L, Santos Noelle Lyn C, Carrillo Julianne Janine V, Fernandez Mikko Glen, Gonzales Gerard Bryan L
Department of Science and Technology - Food and Nutrition Research Institute (DOST-FNRI), Taguig, Philippines.
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, Netherlands.
Front Nutr. 2023 Aug 22;10:1238234. doi: 10.3389/fnut.2023.1238234. eCollection 2023.
Managing nutrition and lifestyle practices, nutrition phenotypes, and the genome forms the foundation of precision nutrition. Precision nutrition focuses on metabolic variability among individuals, and one approach to achieving its goals is to integrate gene-based nutrition and lifestyle recommendations in nutrition practice. However, scientific evidence proving the effectiveness of such recommendations is limited. This study will examine whether providing nutrition and lifestyle recommendations based on individual genotype can lead to better weight loss, along with reduction in body mass index (BMI), waist circumference, and body fat percentage among overweight and obese adults.
A parallel group, single-blind, randomized controlled trial will be conducted. Sixty-two overweight/obese individuals aged 19-59 years old will be recruited. Participants will be randomly allocated to either the intervention ( = 31) or the control arm ( = 31). Participants in the intervention group will receive the MyGeneMyDiet Recommendation for Weight Management, a gene-based nutrition and lifestyle recommendation that was developed based on existing evidence of the effects of rs9939609 on body weight, BMI, and physical activity; rs1800592 on calorie intake; and rs7903146 on dietary fat intake. Participants in the control group will receive the standard recommendations for weight management. The primary outcomes will be the differences in weight, BMI, waist circumference, and body fat percentage between arms in both the active phase (6 months) and inactive phase (last 6 months) of the trial. Participants in both arms will be evaluated at baseline and in months 3, 6, 9, and 12.
To the best of our knowledge, this will be the first gene-based intervention that will adopt a phase of intensive nutrition counseling, followed by a simulation of a free-living state to determine adherence to a gene-based recommendation. This study will contribute to the future implementation of precision nutrition interventions by providing evidence on the effectiveness of a gene-based nutrition and lifestyle recommendation for weight loss.
clinicaltrials.gov, identifier [NCT05098899].
管理营养与生活方式、营养表型及基因组构成了精准营养的基础。精准营养关注个体间的代谢变异性,实现其目标的一种方法是在营养实践中整合基于基因的营养与生活方式建议。然而,证明此类建议有效性的科学证据有限。本研究将考察基于个体基因型提供营养与生活方式建议是否能带来更好的体重减轻效果,同时降低超重和肥胖成年人的体重指数(BMI)、腰围及体脂百分比。
将开展一项平行组、单盲、随机对照试验。招募62名年龄在19至59岁之间的超重/肥胖个体。参与者将被随机分配至干预组(n = 31)或对照组(n = 31)。干预组参与者将接受“我的基因我的饮食体重管理建议”,这是一种基于基因的营养与生活方式建议,它是根据rs9939609对体重、BMI及身体活动的影响、rs1800592对热量摄入的影响以及rs7903146对膳食脂肪摄入的影响的现有证据制定的。对照组参与者将接受体重管理的标准建议。主要结局将是试验活跃期(6个月)和非活跃期(最后6个月)两组之间体重、BMI、腰围及体脂百分比的差异。两组参与者将在基线以及第3、6、9和12个月接受评估。
据我们所知,这将是首个基于基因的干预措施,该措施将采用强化营养咨询阶段,随后模拟自由生活状态以确定对基于基因的建议的依从性。本研究将通过提供基于基因的营养与生活方式建议对体重减轻效果的有效性证据,为精准营养干预措施的未来实施做出贡献。
clinicaltrials.gov,标识符 [NCT05098899]